- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | NSE - IMAC Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
| Sa | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 12.07. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.07. | IMAC Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 30.06. | IMAC Holdings, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 30.06. | IMAC Holdings, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
| 18.06. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.05. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.05. | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 02.05. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.04. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 03.04. | IMAC Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 31.03. | IMAC Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 25.03. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.03. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.02. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 19.02. | IMAC Holdings, Inc.: Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay | 1 | GlobeNewswire (USA) | ||
| 12.02. | IMAC Holdings, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 11.02. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,384 | 0,00 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| LIFEWARD | 0,738 | 0,00 % | Lifeward Ltd.: Administrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare Beneficiary | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| EKSO BIONICS | 3,960 | 0,00 % | Ekso Bionics Holdings, Inc.: Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country | ||
| IMUNON | 0,505 | +7,45 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,950 | +0,37 % | Rockwell Medical signs multi-year supply agreement with Innovative Renal Care | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 14,400 | +1,27 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
| SINTX TECHNOLOGIES | 2,790 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors | New leadership and recapitalization to accelerate commercialization of proprietary silicon nitride technologies in medical and high-growth markets SALT LAKE CITY, Utah, June 12, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| AETHLON MEDICAL | 1,430 | -100,00 % | Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort | SAN DIEGO, July 15, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon... ► Artikel lesen | |
| NEURONETICS | 3,230 | +2,70 % | Neuronetics Appoints New Chief Financial Officer | Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero, ElevationMD use Aristotle to detect cancer | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| HVIVO | 0,100 | -0,50 % | hVIVO PLC - Directorate Change | ||
| FRESENIUS | 40,760 | -0,32 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 45,800 | -0,67 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |
IMAC HOLDINGS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,192 Euro und damit -4,00 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.